The FDA has approved Emrelis for the treatment of adult patients with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

The House Budget Committee plans to try again Sunday night to advance the GOP’s expansive reconciliation package after four Republican dissenters torpedoed the measure at a markup Friday.

The Lakers cannot offer the most competitive trade package on the market due to the team's limited assets, but it could be a decent enough package to get them in the conversation. Antetokounmpo ...

The absence of safety and efficacy data for drugs in individuals with obesity in package inserts may compromise health outcomes. Bruno Halpern, MD, PhD, a specialist in endocrinology and internal ...

Greenville, Michigan, retail advertising insert printing operation by May 16 ... workers will receive a comprehensive separation package that includes severance pay, continuation of healthcare ...

Use a scanner app to take a photo of your signature and insert it as an electronic signature in Word, for example. You can do this with the free OneDrive app from Microsoft, for example.

With the release candidate version 2 presented last week, Apple also provided a package insert for the first time. This contains an overview of the new features. It includes some exciting details ...

An easy solution is to invest in a package delivery box to keep your items safe while also protecting them from weather damage. The most basic package delivery boxes are empty containers with a ...

Novartis announced positive, longer-term results from the pivotal phase III ASC4FIRST trial with Scemblix (asciminib) showing superior major molecular response (MMR) rates at week 961. The study ...

Novartis (NVS) announced “positive,” longer-term results from the pivotal Phase 3 ASC4FIRST trial with Scemblix showing superior major molecular response rates at week 96. The study compared ...

Scemblix outperformed standard TKIs in 96-week MMR rates, showing significant efficacy in CML treatment. FDA accelerated approval was based on 48-week data, highlighting Scemblix's early promise.

THE precursor of the current storm surrounding the heretofore innocuous package insert was a malpractice case against a New York dentist in which the insert in a package of epinephrine with ...